论文信息 - Treatment of Diabetes with L363,586 - 字舞流文

Treatment of Diabetes with L363,586

G. Bolli | J. Gerich | P. Campbell | I. Gottesman | F. Kennedy

[1] J. Gerich,et al. Prevention of the Dawn phenomenon (early morning hyperglycemia) in insulin-dependent diabetes mellitus by bedtime intranasal administration of a long-acting somatostatin analog. , 1988, Metabolism: clinical and experimental.

[2] J. Gerich,et al. Efficacy, pharmacokinetics and tolerability of a somatostatin analogue (L-363,586) in insulin-dependent diabetes mellitus. , 1986, Life sciences.

[3] P. Cryer,et al. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. , 1985, The New England journal of medicine.

[4] W. Blackard,et al. Pump-induced Insulin Aggregation: A Problem with the Biostator , 1985, Diabetes.

[5] P. Brunetti,et al. Demonstration of a Dawn Phenomenon in Normal Human Volunteers , 1984, Diabetes.

[6] G. Bolli,et al. The "dawn phenomenon"--a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. , 1984, The New England journal of medicine.

[7] D. Veber,et al. A super active cyclic hexapeptide analog of somatostatin. , 1984, Life sciences.

[8] M. Lorenzi,et al. Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus. , 1975, JAMA.